Magnetoliposomes as Carriers for CRISPR/nCas9-Based Gene Therapy on In Vitro Models of Mucopolysaccharidoses IVA and GM2 Gangliosidoses: Proof-of-Concept Experiments

AF Leal; D Suarez; V Quezada; CE Torres; SC Gómez; J Espejo-Mojica; J Cifuentes; JC Cruz; LH Reyes; CJ Alméciga-Díaz

Magnetoliposomes as Carriers for CRISPR/nCas9-Based Gene Therapy on In Vitro Models of Mucopolysaccharidoses IVA and GM2 Gangliosidoses: Proof-of-Concept Experiments

AF Leal
, D Suarez
, V Quezada
, CE Torres
, SC Gómez
, J Espejo-Mojica
, J Cifuentes
, JC Cruz
, LH Reyes
, CJ Alméciga-Díaz

Instituto de Errores Innatos del Metabolismo

Producción: Contribución a una revista › Resumen de la jornada › revisión exhaustiva

Idioma original	Inglés
Páginas (desde-hasta)	475-476
Número de páginas	2
Publicación	Molecular Therapy
Volumen	30
N.º	4
Estado	Publicada - abr 2022

Otros archivos y enlaces

Ver registro en Web of Science

Citar esto

@article{b66f7d124e1b47fc8801e880b5a01f63,

title = "Magnetoliposomes as Carriers for CRISPR/nCas9-Based Gene Therapy on In Vitro Models of Mucopolysaccharidoses IVA and GM2 Gangliosidoses: Proof-of-Concept Experiments",

author = "AF Leal and D Suarez and V Quezada and CE Torres and SC G{\'o}mez and J Espejo-Mojica and J Cifuentes and JC Cruz and LH Reyes and CJ Alm{\'e}ciga-D{\'i}az",

year = "2022",

month = apr,

language = "English",

volume = "30",

pages = "475--476",

journal = "Molecular Therapy",

issn = "1525-0016",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - Magnetoliposomes as Carriers for CRISPR/nCas9-Based Gene Therapy on In Vitro Models of Mucopolysaccharidoses IVA and GM2 Gangliosidoses

T2 - Proof-of-Concept Experiments

AU - Leal, AF

AU - Suarez, D

AU - Quezada, V

AU - Torres, CE

AU - Gómez, SC

AU - Espejo-Mojica, J

AU - Cifuentes, J

AU - Cruz, JC

AU - Reyes, LH

AU - Alméciga-Díaz, CJ

PY - 2022/4

Y1 - 2022/4

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_puj3&SrcAuth=WosAPI&KeyUT=WOS:000794043702192&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 1525-0016

VL - 30

SP - 475

EP - 476

JO - Molecular Therapy

JF - Molecular Therapy

IS - 4

ER -